These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 5898681)

  • 1. Studies on progressive muscular dystrophy. II. Relation between clinical effect of adenosinetriphosphate on progressive muscular dystrophy and phosphate compounds in the muscle.
    Nakahara M
    Arzneimittelforschung; 1965 Jul; 15(7):782-5. PubMed ID: 5898681
    [No Abstract]   [Full Text] [Related]  

  • 2. [New aspects of the management of progressive muscular dystrophy].
    Tilscher H; Schenk S
    Wien Med Wochenschr; 1967 Nov; 117(44):1000-2. PubMed ID: 5591872
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies on progressive muscular dystrophy. 3. Breakdown of adenosine nucleotides in human blood.
    Nakahara M
    Arzneimittelforschung; 1965 Aug; 15(8):932-4. PubMed ID: 5898654
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies on progressive muscular dystrophy. IV. Effects of original amino acids mixture on progressive muscular dystrophy.
    Nakahara M; Yamada S
    Arzneimittelforschung; 1967 Jun; 17(6):753-6. PubMed ID: 5632380
    [No Abstract]   [Full Text] [Related]  

  • 5. [Therapeutic possibilities in progressive muscular dystrophy].
    Beckmann R; von Osten V
    Dtsch Med Wochenschr; 1966 Jan; 91(3):108-16. PubMed ID: 5901816
    [No Abstract]   [Full Text] [Related]  

  • 6. Studies on progressive muscular dystrophy. I. Effects of adenosinetriphosphate and its related compounds on progressive muscular dystrophy.
    Nakahara M
    Arzneimittelforschung; 1965 Jun; 15(6):591-5. PubMed ID: 4223122
    [No Abstract]   [Full Text] [Related]  

  • 7. [Therapy and macroergic phosphoric compounds in Duchenne's progressive muscular dystrophy].
    Radu H; Stenzel K; Blücher G; Gödri I
    Neurol Psihiatr Neurochir; 1969; 14(5):435-42. PubMed ID: 5380160
    [No Abstract]   [Full Text] [Related]  

  • 8. [Lipoid changes in progressive muscular dystrophy].
    Schellnack K
    Beitr Orthop Traumatol; 1970 Jan; 17(1):91-5. PubMed ID: 5511214
    [No Abstract]   [Full Text] [Related]  

  • 9. Chronic allopurinol and adenine therapy in Duchenne muscular dystrophy: effects on muscle function, nucleotide degradation, and muscle ATP and ADP content.
    Bertorini TE; Palmieri GM; Griffin J; Chesney C; Pifer D; Verling L; Airozo D; Fox IH
    Neurology; 1985 Jan; 35(1):61-5. PubMed ID: 3880875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Progressive muscular dystrophy].
    Tsuji S; Kato F; Osawa K
    Naika; 1967 Jun; 19(6):1301-3. PubMed ID: 4865513
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment problems using anabolic steroids in progressive muscular dystrophy].
    Badalian LO; Temin PA; Mukhin KIu
    Klin Med (Mosk); 1984 Nov; 62(11):23-9. PubMed ID: 6394898
    [No Abstract]   [Full Text] [Related]  

  • 12. [Characteristics of carbohydrate-phosphorus and electrolyte metabolism in the erythrocytes of patients with progressive muscular dystrophy and in their closest relations].
    Degtiar VV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1974; 74(3):333-41. PubMed ID: 4466265
    [No Abstract]   [Full Text] [Related]  

  • 13. [The treatment of progressive muscular dystrophy with nucleosides and nucleotides. Clinical and serologic findings (aldolase and creatinphosphokinase)].
    Ceccarelli A; Leone P; Moretti A
    Clin Pediatr (Bologna); 1967 Sep; 49(9):468-75. PubMed ID: 5608288
    [No Abstract]   [Full Text] [Related]  

  • 14. Hyperbaric oxygen therapy for muscular dystrophy.
    Hirotani H; Kuyama T
    Nihon Geka Hokan; 1974 Mar; 43(2):161-7. PubMed ID: 4473049
    [No Abstract]   [Full Text] [Related]  

  • 15. [The treatment of progressive muscular dystrophy (Erb) with adenosine triphosphate].
    STELGENS P
    Dtsch Med Wochenschr; 1957 Oct; 82(41):1761-3. PubMed ID: 13473545
    [No Abstract]   [Full Text] [Related]  

  • 16. Oxidative phosphorylation and glycolysis in the hereditary muscular dystrophy of the Syrian hamster.
    Lochner A; Brink AJ
    Clin Sci; 1967 Oct; 33(2):409-23. PubMed ID: 6058438
    [No Abstract]   [Full Text] [Related]  

  • 17. STUDIES ON THE TREATMENT OF MYOPATHIES WITH SPECIAL REFERENCE TO FROZEN BLOOD THERAPY TO PROGRESSIVE MUSCULAR DYSTROPHIES.
    KATSUKI S; KUROIWA Y; MIYAZAKI T
    Kyushu J Med Sci; 1963 Aug; 14():175-88. PubMed ID: 14061431
    [No Abstract]   [Full Text] [Related]  

  • 18. Abnormal polyamine metabolism in hereditary muscular dystrophies: effect of human growth hormone.
    Rudman D; Kutner MH; Chawla RK; Goldsmith MA
    J Clin Invest; 1980 Jan; 65(1):95-102. PubMed ID: 7350201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapy of progressive muscular dystrophy].
    MIEHLKE K
    Schweiz Med Wochenschr; 1957 Jun; 87(26):864-6. PubMed ID: 13454770
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of progressive muscular dystrophy with adenosintriphosphoric acid].
    MAN'KOVSKII BN; SLONIMSKAIA VM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1955 Jan; 55(1):43-7. PubMed ID: 14375308
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.